Related Experiment Video
Updated: Sep 13, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Intrinsic capacity in Lewy body dementia: a review
Federica Sanapo1, Marie Signoret2, Mihaela Nodit3
1Paris-Saclay University, Versailles Saint Quentin-en-les-Yvelines University, Faculty of Medicine Simone Veil, Versailles, France; Department of medicine of older adults, Sainte-Perine Hospital, Assistance Publique - Hopitaux de Paris, Paris, France.
Abstract:
Frailty is a clinical syndrome characterized by diminished physiological reserves and increased vulnerability to stressors. While frailty has been largely studied in Alzheimer's disease, few study focused on Lewy body dementia (LBD). Beyond frailty, the World Health Organization recently highlights the concept of intrinsic capacity (IC), offering a promising framework for the early identification and intervention to mitigate the risk of frailty and disability in older adults. IC refers to an individual's physical and mental abilities (including five dimensions: sensory, psychology, locomotion, vitality and cognition), which support the maintenance of functional capacity and promote healthy aging. In this review, we aimed to describe the prevalence of IC decline in LBD and its potential consequences. While few studies focused specifically on this question, we found evidence in the literature of a higher prevalence of IC decline in LBD, compared to cognitively unimpaired older adults and to Alzheimer's disease patients. If future studies are needed to confirm these results, we assume that IC assessment and monitoring in LBD may be a further step towards a better integrated and personalized care for patients. This may open the avenue to develop specific tailored interventions, to decrease disability and increase quality of life and "healthy ageing" of patients despite the presence of LBD.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Related Concept Videos
Neural Regulation
Lysosomal Hydrolases
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...